Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

AmBisome approved in Korea

Aug. 8, 1997

Shionogi's beta-lactam antibiotic launched in Japan

Aug. 7, 1997

CytoGam approved for marketing in Canada

Aug. 7, 1997

AmBisome approved in Russia

Aug. 7, 1997

New cephems active against MRSA

Aug. 6, 1997

BE-44651B disclosed in patent literature by Banyu

Aug. 6, 1997

EGS oligozymes make drug-resistant bacteria sensitive

Aug. 5, 1997

New oxazolidinones from P&U

Aug. 4, 1997

Grepafloxacin receives first approval in Germany

Aug. 4, 1997

Grepafloxacin efficacy in respiratory infections reported

Aug. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...